Ban & Monetization Policy
MyLiveRoom Rewards Program Rules & Eligibility
0 Comments
0 Shares
414 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Precision Oncology Drug Portfolio Market Size, Industry Development and Forecast Insights"Executive Summary Precision Oncology Drug Portfolio Market Market: Share, Size & Strategic Insights The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the forecast period This Precision Oncology Drug Portfolio Market Market...0 Comments 0 Shares 2K Views 0 Reviews
-
Advances in Oncology Research Driving the Metastatic Solid Tumors MarketComprehensive Outlook on Executive Summary Metastatic Solid Tumors Market Size and Share CAGR Value Data Bridge Market Research analyses a growth rate in the global metastatic solid tumors market in the forecast period 2022-2029 Metastatic Solid Tumors Market research report unearths different industry verticals such as company profile, contact details of manufacturer, product...0 Comments 0 Shares 4K Views 0 Reviews
-
Anal Cancer Drug Market: Chemotherapy, Targeted Therapies, and Immunotherapy Treatment Strategies in Oncology"Executive Summary Anal Cancer Drug Market Research: Share and Size Intelligence The global anal cancer drug market size was valued at USD 401.57 million in 2024 and is projected to reach USD 1,199.82 million by 2032, with a CAGR of 13.80 % during the forecast period of 2025 to 2032. Best-practice models and research methodologies have been employed in the reliable Anal Cancer Drug Market...0 Comments 0 Shares 3K Views 0 Reviews
-
Antiemetics Market Growth Addressing Nausea Management Across Oncology and Postoperative CareGlobal Demand Outlook for Executive Summary Antiemetics Market Size and Share CAGR Value The global antiemetics market size was valued at USD 39.68 billion in 2025 and is expected to reach USD 61.87 billion by 2033, at a CAGR of 5.71% during the forecast period The wide-ranging report deals with the new business challenges and investment research on Antiemetics Marketwhich includes...0 Comments 0 Shares 2K Views 0 Reviews
-
Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market: Targeted Oncology Therapies, Precision Medicine for Lung and Colorectal Cancer"Future of Executive Summary Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market: Size and Share Dynamics Data Bridge Market Research analyses that the market is growing with a CAGR of 10.4% in the forecast period of 2021 to 2028 and is expected to reach 358.26 million by 2028. The Asia-Pacific Kirsten Rat Sarcoma (KRAS) report encompasses the key developments in the market with respect to...0 Comments 0 Shares 2K Views 0 Reviews
-
Cancer Biomarkers Market Drivers: Shaping the Future of Precision OncologyThe landscape of modern medicine is being redefined by the rapid evolution of the Cancer Biomarkers Market Drivers, which are fundamentally changing how clinicians approach the diagnosis and treatment of malignancies. As of 2026, the shift from generalized chemotherapy to molecularly targeted therapies has turned biological indicators into the most valuable assets in the clinical toolkit. These...0 Comments 0 Shares 2K Views 0 Reviews
-
Cancer Immunotherapy Market Strengthens with Growing Approvals for Novel Immuno-Oncology DrugsThe global cancer immunotherapy market is witnessing remarkable growth due to the increasing prevalence of cancer, rising investments in oncology research, and growing adoption of advanced immunotherapy treatments worldwide. The market was valued at USD 150.12 billion in 2024 and is projected to grow from USD 170.28 billion in 2025 to USD 457.04 billion by 2032, exhibiting a...0 Comments 0 Shares 333 Views 0 Reviews
-
Cancer Treatment Drugs Market to Reach USD 359.83 Billion by 2032 Driven by Immunotherapy and Precision Oncology AdvancementsAccording to a report by Intel Market Research, the global cancer treatment drugs market was valued at USD 193.12 billion in 2024 and is projected to grow from USD 211.45 billion in 2025 to USD 359.83 billion by 2032, exhibiting a CAGR of 9.5% during the forecast period. The market is witnessing strong growth due to the rising global burden of cancer, increasing adoption of targeted therapies...0 Comments 0 Shares 346 Views 0 Reviews
-
Carcinoembryonic Antigen (CEA) Market: Cancer Biomarker Testing, Diagnostic Kits, and Monitoring Applications in OncologyExecutive Summary: The Global Carcinoembryonic Antigen (CEA) Market is a vital segment within the cancer diagnostics and tumor marker industry. CEA is a glycoprotein primarily used as a non-specific serum biomarker to monitor treatment efficacy, detect disease recurrence, and provide prognostic information for several cancers, most notably colorectal cancer (CRC). The market is...0 Comments 0 Shares 2K Views 0 Reviews
-
Liquid Biopsy Market Trends in Minimally Invasive Diagnostic ProceduresThe global Liquid Biopsy Market size was estimated at USD 13.60 billion in 2025 and is projected to reach USD 32.57 billion by 2033, growing at a CAGR of 11.52% from 2026 to 2033. The market is experiencing significant growth due to the rising prevalence of cancer worldwide, rapid advancements in cancer diagnostics, and the increasing preference for minimally invasive testing methods....0 Comments 0 Shares 258 Views 0 Reviews
-
Artificial Intelligence in Cancer Diagnosis: Improving Early DetectionArtificial intelligence is revolutionizing cancer diagnosis by enabling faster, more accurate, and highly efficient disease detection. Advanced AI-powered systems are helping healthcare providers analyze medical imaging, pathology slides, and genomic data with greater precision than traditional diagnostic methods. These innovations are contributing significantly to the rapid growth of the...0 Comments 0 Shares 620 Views 0 Reviews
-
Burkitt Lymphoma Therapeutics Market Size, Share & Growth Analysis Report 2025–2034Get Your Sample Report Here: https://reedintelligence.com/market-analysis/burkitt-lymphoma-therapeutics-market/request-sample Buy Now: https://reedintelligence.com/market-analysis/burkitt-lymphoma-therapeutics-market Burkitt Lymphoma Therapeutics Market Overview The global Burkitt Lymphoma Therapeutics Market is experiencing significant growth due to the increasing prevalence of lymphoma...0 Comments 0 Shares 908 Views 0 Reviews
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Comments 0 Shares 5K Views 0 Reviews
-
Chemotherapy Induced Anemia Market Size, Trends, and Growth StrategiesThe chemotherapy induced anemia market is witnessing steady growth driven by rising cancer prevalence and advancements in anemia management therapies. Increasing demand for effective anemia treatment options and enhanced diagnostic capabilities are reshaping market dynamics, with notable shifts in market trends poised to influence business growth globally.Market Size and Overview The...0 Comments 0 Shares 1K Views 0 Reviews
-
Clinical Oncology Next Generation Sequencing Market Market Size, Top Industry Players and Forecast to 2033Clinical Oncology Next Generation Sequencing Industry Outlook: Straits Research has added a report titled “Global Clinical Oncology Next Generation Sequencing Market Professional Report 2025-2033” to its database of research reports. The study provides complete details about the usage and adoption of Clinical Oncology Next Generation Sequencing in various industrial applications...0 Comments 0 Shares 2K Views 0 Reviews
-
Clinical Trials Site Market Developments Across Healthcare Research NetworksThe global clinical trials site market size was valued at USD 6.72 billion in 2024 and is projected to grow from USD 7.14 billion in 2025 to USD 11.57 billion by 2033 at a CAGR of 6.22% during the forecast period (2025-2033). Key Highlights North America dominated the global clinical trials site market. Asia-Pacific is expected to be the fastest-growing region during the forecast...0 Comments 0 Shares 2K Views 0 Reviews
-
Emerging Trends Influencing the Antibody Drug Conjugates MarketAsia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...0 Comments 0 Shares 8K Views 0 Reviews
More Results
© 2026 Myliveroom — Live Events & Online Communities
English
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
